SYNLAB enters Nigerian market, acquires majority stake in PathCare Nigeria

L-R: Chairman, PathCare Nigeria, Dr. Richard Ajayi; Managing Director, PathCare Nigeria, Dr. Pamela Ajayi; CEO, Synlab Emerging Markets, Thomas Degott; Executive Director, Operations - PathCare Nigeria, Dr. Tolu Adewole at the Press Conference announcing SYNLAB's major acquisition of majority stake in Pathcare Nigeria.

SYNLAB, the leading provider of medical diagnostic services in Europe, yesterday announced the acquisition of a majority stake in PathCare Nigeria Limited, the largest private medical laboratory group in Nigeria.

With this step, SYNLAB enters the private medical laboratory market in Nigeria.

PathCare Nigeria is a market leader in Nigeria in the field of human laboratory diagnostics, with a special focus on public private partnerships. Its strong market position is based on its high-quality service, the breadth of its test portfolio, and its nationwide network.

The transaction with SYNLAB allows PathCare Nigeria the ability to offer its Nigerian customers an extended portfolio of specialised tests being sourced from the SYNLAB network.

The company will benefit from the technological advancements and comprehensive cost-effective solutions to enhance the local business with hospitals and other customers.

With more than 200 employees, PathCare Nigeria operates six laboratories and 21 blood collection points across Nigeria and is engaged in a public private partnership with the leading public hospital in Lagos, the largest city in Africa.

Thomas Degott, CEO of SYNLAB Emerging Markets, commented: “Nigeria has a population of about 186 million, but a large proportion of the population does not yet have access to modern medical diagnostics. PathCare Nigeria’s customers will benefit from an enhanced test portfolio drawing from the breadth and depth of SYNLAB’s international expertise.”

Dr. Pamela Ajayi, Managing Director, PathCare Nigeria, said the company is “pleased to be joining the SYNLAB group.

“There will be huge advantages to having the European Diagnostic Leader in Nigeria, bringing the most modern technological advancements in the field within the reach of every Nigerian. PathCare Nigeria will continue to push the boundaries. We also expect this investment to have a positive impact on healthcare development in the Country.”

Support PREMIUM TIMES' journalism of integrity and credibility

 

Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.

For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble endeavour.

By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.

Donate


NEVER MISS A THING AGAIN! Subscribe to our newsletter

* indicates required

DOWNLOAD THE PREMIUM TIMES MOBILE APP

Now available on

  Premium Times Android mobile applicationPremium Times iOS mobile applicationPremium Times blackberry mobile applicationPremium Times windows mobile application

TEXT AD: New Discovery! Click Here To See A Miracle Device That Can Cure DIABETES, BLOOD PRESSURE, STROKE, ARTHRITIS, PAINS, OBESITY And 50 Other CHRONIC DISEASES Without Drugs Or Herbs.. Click Here Now To See It


All rights reserved. This material and any other material on this platform may not be reproduced, published, broadcast, written or distributed in full or in part, without written permission from PREMIUM TIMES.